Site Announcement
For the latest results and update on CytoDyn’s Phase 2 CRC trial and more, here’s a link to our April 30, 2026 investor update webinar
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 07/07/17 | 8-K | Current report filing |
|
5 | |
| 06/22/17 | 8-K | Current report filing |
|
64 | |
| 06/21/17 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 06/14/17 | D | Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(a)(5) under the Act. |
|
6 | |
| 06/05/17 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 06/05/17 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 06/05/17 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 06/05/17 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 06/05/17 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 06/05/17 | 4 | Statement of changes in beneficial ownership of securities |
|
1 |
